MedTrace Logo

International Validation of Two Non-motor Scales in PD (NFS and SPARK)

NCT04366804 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-04-13

No results posted yet for this study

Summary

The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).

Conditions

Sponsors & Collaborators

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • Carlos III Health Institute

    collaborator OTHER_GOV

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Paul Krack, MD, PhD · Insel Gruppe AG, University Hospital Bern

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-03
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • France
  • Germany
  • Greece
  • Romania
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366804 on ClinicalTrials.gov